Evidence map›Paper›PMID 32668454›Full record

ArticleThe Journal of infectious diseases2021

Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.

Alexandria D Tricoche, Abram L Wagner, Angel Balmaseda, Nery Sanchez, Mayuri Patel, Roger Lopez, Amy Schiller, Sergio Ojeda, Aaron M Frutos, Guillermina Kuan and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Alexandria D TricocheDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Abram L WagnerDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Angel BalmasedaLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Nery SanchezSustainable Sciences Institute, Managua, Nicaragua.
Mayuri PatelDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Roger LopezLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua.
Amy SchillerDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Sergio OjedaSustainable Sciences Institute, Managua, Nicaragua.
Aaron M FrutosDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Guillermina KuanSustainable Sciences Institute, Managua, Nicaragua.
Aubree GordonDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · USNational Autonomous University of Nicaragua · NISustainable Sciences Institute · USMinisterio de Salud · NI

Funding

Flu Dynamics COVID-19 SupplementR01AI120997 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GORDON, AUBREE L · 2017 to 2021
$4.1M
Epidemiology and Transmission of Influenza in NicaraguaK02TW009483 · FIC · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GORDON, AUBREE L · 2012 to 2016
$419k
FIC NIH HHS K02 TW009483NIAID NIH HHS HHSN272201400006CNIAID NIH HHS R01 AI120997
6 · The paper itself

Abstract

backgroundMany influenza studies assume that symptomatic and asymptomatic cases have equivalent antibody responses.

methodsThis study examines the relationship between influenza symptoms and serological response. Influenza-positive index cases and household members in Managua, Nicaragua, during 2012-2017 were categorized by symptom status.

resultsAntibody response was assessed using hemagglutination inhibition assays (HAI). Among 510 cases, 74.5% had ≥4-fold increase in HAI antibodies, and 75.3% had febrile illness. In a logistic regression model, febrile cases had 2.17 times higher odds of a ≥4-fold titer rise compared to asymptomatic cases (95% confidence interval, 1.02-4.64).

conclusionsStudies relying on serological assays may not generalize to asymptomatic infections.

Indexed as

Antibodies, ViralHemagglutination Inhibition TestsAntibody FormationAsymptomatic InfectionsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanNicaraguaAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virusantibodieshemagglutination inhibition testsinfectious disease transmissioninfluenza A virussigns and symptoms

Identifiers

PMID32668454
PMCPMC7938177
OpenAlexW3043127340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.